Terms: = Brain cancer AND PTEN, MMAC1, 5728, MGC11227, PTEN1, MHAM, P60484, BZS, ENSG00000171862 AND Diagnosis
145 results:
1. Glioblastoma Therapy: Past, Present and Future.
Obrador E; Moreno-Murciano P; Oriol-Caballo M; López-Blanch R; Pineda B; Gutiérrez-Arroyo JL; Loras A; Gonzalez-Bonet LG; Martinez-Cadenas C; Estrela JM; Marqués-Torrejón MÁ
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473776
[TBL] [Abstract] [Full Text] [Related]
2. brain metastasis in a patient with BRCA2-mutated treatment-related neuroendocrine prostate carcinoma and long-term response to radiotherapy and Olaparib: A case report and literature review.
Uehara R; Obinata D; Hashimoto S; Nakahara K; Uchida H; Yoshizawa T; Mochida J; Yamaguchi K; Sakaguchi M; Ozawa Y; Mori F; Miura K; Ishige T; Masuda S; Nakayama T; Takahashi S
Medicine (Baltimore); 2024 Mar; 103(9):e37371. PubMed ID: 38428891
[TBL] [Abstract] [Full Text] [Related]
3. Reliable detection of genetic alterations in cyst fluid DNA for the diagnosis of brain tumors.
On J; Natsumeda M; Takahashi H; Koyama A; Shibuma S; Shibata N; Watanabe J; Saito S; Kanemaru Y; Tsukamoto Y; Okada M; Ogura R; Eda T; Tada M; Shimizu H; Adachi JI; Mishima K; Nishikawa R; Kakita A; Oishi M
J Neurooncol; 2024 Jan; 166(2):273-282. PubMed ID: 38227143
[TBL] [Abstract] [Full Text] [Related]
4. "De novo replication repair deficient glioblastoma, IDH-wildtype" is a distinct glioblastoma subtype in adults that may benefit from immune checkpoint blockade.
Hadad S; Gupta R; Oberheim Bush NA; Taylor JW; Villanueva-Meyer JE; Young JS; Wu J; Ravindranathan A; Zhang Y; Warrier G; McCoy L; Shai A; Pekmezci M; Perry A; Bollen AW; Phillips JJ; Braunstein SE; Raleigh DR; Theodosopoulos P; Aghi MK; Chang EF; Hervey-Jumper SL; Costello JF; de Groot J; Butowski NA; Clarke JL; Chang SM; Berger MS; Molinaro AM; Solomon DA
Acta Neuropathol; 2023 Dec; 147(1):3. PubMed ID: 38079020
[TBL] [Abstract] [Full Text] [Related]
5. Role of exosomal
Ashraf NS; Mahjabeen I; Hussain MZ; Rizwan M; Arshad M; Mehmood A; Haris MS; Kayani MA
Future Oncol; 2023 Jul; 19(22):1563-1576. PubMed ID: 37577782
[No Abstract] [Full Text] [Related]
6. Intracranial mesenchymal tumor with (novel) COX14::pten rearrangement.
d'Amati A; Gianno F; Scuccimarri L; Lastilla M; Messina R; Signorelli F; Zimatore DS; Barresi S; Miele E; Alaggio R; Rossi S; Maiorano E; Ingravallo G; Giangaspero F; Antonelli M
Acta Neuropathol Commun; 2023 Jun; 11(1):95. PubMed ID: 37312212
[TBL] [Abstract] [Full Text] [Related]
7. Clinical and Proteomic-Based Molecular Characterizations of Invasive and Noninvasive Somatotroph PitNETs.
Chen M; Duan L; Sun W; Guo Z; Miao H; Yu N; Yang S; Wang L; Gong F; Yao Y; Zhu H
Neuroendocrinology; 2023; 113(9):971-986. PubMed ID: 37253344
[TBL] [Abstract] [Full Text] [Related]
8. Clinical and genetic diagnosis of Cowden syndrome: A case report of a rare pten germline variant and diverse clinical presentation.
Arai H; Akagi K; Nakagawa A; Onai Y; Utsu Y; Masuda S; Aotsuka N
Medicine (Baltimore); 2023 Jan; 102(1):e32572. PubMed ID: 36607858
[TBL] [Abstract] [Full Text] [Related]
9. Thyroid carcinoma metastases to central nervous system and vertebrae.
Kleinschmidt-DeMasters B; Marshall C
Folia Neuropathol; 2022; 60(3):292-300. PubMed ID: 36382481
[TBL] [Abstract] [Full Text] [Related]
10. A progressive and refractory case of breast cancer with Cowden syndrome.
Sueta A; Takeno M; Goto-Yamaguchi L; Tomiguchi M; Inao T; Yamamoto-Ibusuki M; Yamamoto Y
World J Surg Oncol; 2022 Sep; 20(1):279. PubMed ID: 36057718
[TBL] [Abstract] [Full Text] [Related]
11. Nervous system (NS) Tumors in cancer Predisposition Syndromes.
Patil P; Pencheva BB; Patil VM; Fangusaro J
Neurotherapeutics; 2022 Oct; 19(6):1752-1771. PubMed ID: 36056180
[TBL] [Abstract] [Full Text] [Related]
12. Molecular Genetic Profile of 300 Japanese Patients with Diffuse Gliomas Using a Glioma-tailored Gene Panel.
Higa N; Akahane T; Yokoyama S; Yonezawa H; Uchida H; Fujio S; Kirishima M; Takigawa K; Hata N; Toh K; Yamamoto J; Hanaya R; Tanimoto A; Yoshimoto K
Neurol Med Chir (Tokyo); 2022 Sep; 62(9):391-399. PubMed ID: 36031351
[TBL] [Abstract] [Full Text] [Related]
13. Coexisting lipomatous meningioma and glioblastoma in Cowden syndrome: A unique tumor association.
Prieto R; Hofecker V; Corbacho C
Neuropathology; 2023 Feb; 43(1):110-116. PubMed ID: 36003032
[TBL] [Abstract] [Full Text] [Related]
14. The clinical significance of adenomatous polyposis coli (APC) and catenin Beta 1 (CTNNB1) genetic aberrations in patients with melanoma.
Karachaliou GS; Alkallas R; Carroll SB; Caressi C; Zakria D; Patel NM; Trembath DG; Ezzell JA; Pegna GJ; Googe PB; Galeotti JP; Ayvali F; Collichio FA; Lee CB; Ollila DW; Gulley ML; Johnson DB; Kim KB; Watson IR; Moschos SJ
BMC Cancer; 2022 Jan; 22(1):38. PubMed ID: 34986841
[TBL] [Abstract] [Full Text] [Related]
15. IDH-wild type glioblastomas featuring at least 30% giant cells are characterized by frequent RB1 and NF1 alterations and hypermutation.
Barresi V; Simbolo M; Mafficini A; Martini M; Calicchia M; Piredda ML; Ciaparrone C; Bonizzato G; Ammendola S; Caffo M; Pinna G; Sala F; Lawlor RT; Ghimenton C; Scarpa A
Acta Neuropathol Commun; 2021 Dec; 9(1):200. PubMed ID: 34952640
[TBL] [Abstract] [Full Text] [Related]
16. Pathological and genomic phenotype of second neuroendocrine carcinoma during long-term follow-up after radical radiotherapy for nasopharyngeal carcinoma.
Peng YP; Liu QD; Lin YJ; Peng SL; Wang R; Xu XW; Wei W; Zhong GH; Zhou YL; Zhang YQ; Liu Y; Wang SY; Hong HY; Liu ZG
Radiat Oncol; 2021 Oct; 16(1):198. PubMed ID: 34635145
[TBL] [Abstract] [Full Text] [Related]
17. Molecular Alterations in Pediatric Low-Grade Gliomas That Led to Death.
Ahrendsen JT; Sinai C; Meredith DM; Malinowski SW; Cooney TM; Bandopadhayay P; Ligon KL; Alexandrescu S
J Neuropathol Exp Neurol; 2021 Nov; 80(11):1052–1059. PubMed ID: 34580728
[TBL] [Abstract] [Full Text] [Related]
18. Efficacy of osimertinib plus bevacizumab in glioblastoma patients with simultaneous EGFR amplification and EGFRvIII mutation.
Cardona AF; Jaramillo-Velásquez D; Ruiz-Patiño A; Polo C; Jiménez E; Hakim F; Gómez D; Ramón JF; Cifuentes H; Mejía JA; Salguero F; Ordoñez C; Muñoz Á; Bermúdez S; Useche N; Pineda D; Ricaurte L; Zatarain-Barrón ZL; Rodríguez J; Avila J; Rojas L; Jaller E; Sotelo C; Garcia-Robledo JE; Santoyo N; Rolfo C; Rosell R; Arrieta O
J Neurooncol; 2021 Sep; 154(3):353-364. PubMed ID: 34498213
[TBL] [Abstract] [Full Text] [Related]
19. Next-Generation Sequencing in the diagnosis of Metastatic Lesions: Reclassification of a Glioblastoma as an Endometrial cancer Metastasis to the brain.
Leung SOA; Foley O; Chapel D; Da Silva A; Nucci M; Muto MG; Campos S
Oncologist; 2021 Dec; 26(12):e2102-e2109. PubMed ID: 34355460
[TBL] [Abstract] [Full Text] [Related]
20. Gliosarcoma with PNET features mimicking a metastatic neuroendocrine carcinoma: A diagnostic dilemma.
McGahan BG; Toop N; Ward S; Jones D; Kobalka PJ; Palmer JD; Elder JB
Clin Neuropathol; 2021; 40(5):279-285. PubMed ID: 34190681
[TBL] [Abstract] [Full Text] [Related]
[Next]
